Constitutively active BTG2 in human leukemia U937 cells, induces G2/M cell cycle arrest by inhibiting the formation of the cyclin B1 and Cdc2 complex, thereby inhibiting the active kinase function of the complex [30]. Here, BTG2 is linked to leukemia.